Jinwen Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jinwen Wang has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Jun Hu
Department of Orthopedics, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
2 shared publications Bin Wan
Department of Orthopedics, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
1 shared publicationFeng Liu
Department of Orthopaedics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
1 shared publication- Hao Zhou
Department of Orthopaedics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
1 shared publication Hongtao Xu
Department of Orthopaedics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
1 shared publicationHuanghe Song
Department of Orthopaedics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by Wiley in Advanced Science
- Vol. 13 (60) , e76930
Systematic Multi‐Level Analyses Decode the Arthritis‐Neurodegeneration Axis With In Vivo Validation
Arthritis may influence neurodegenerative risk, but directionality and mediators remain unclear. This study integrates population survival analysis, Mendelian randomization, transcriptomic mapping, and mouse perturbation to map osteoarthritis (OA)/rheumatoid arthritis (RA) links with five neurodegenerative outcomes and prioritize mediators. In 310 162 European‐ancestry UK Biobank participants, Cox models associate OA with higher risks of Alzheimer's disease (AD; hazard ratio: 1.13, 95% confidence interval: 1.04–1.22), Parkinson's disease (PD; 1.10, 1.00–1.21), and disorders of autonomic nervous system (DANS; 1.36, 1.06–1.74), and RA with higher AD risk (1.37, 1.13–1.67) (all p < 0.05), but not incident PD. Mendelian randomization prioritizes a modest protective genetic effect of RA on PD (odds ratio: 0.93, 0.88–0.99; p = 0.015), without reverse causation. Transcriptome‐wide association and colocalization analyses identify shared RA–PD genes and prioritize Ring Finger Protein 40 ( RNF40 ). In a collagen‐induced arthritis (CIA) and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model, CIA attenuates dopaminergic injury, whereas systemic Rnf40 knockdown alleviates arthritis but exacerbates Parkinsonian pathology. Endogenous RNF40 is induced in arthritic joints but remains stable in midbrain. These cross‐layer data define arthritis–neurodegeneration connections and nominate RNF40 as a context‐dependent joint–brain candidate linking inflammatory arthritis with dopaminergic vulnerability.
- 5 August 2026
- Published by Wiley in Advanced Science
- Vol. 13 (60) , e76930
Open AccessSystematic Multi‐Level Analyses Decode the Arthritis‐Neurodegeneration Axis With In Vivo Validation
Arthritis may influence neurodegenerative risk, but directionality and mediators remain unclear. This study integrates population survival analysis, Mendelian randomization, transcriptomic mapping, and mouse perturbation to map osteoarthritis (OA)/rheumatoid arthritis (RA) links with five neurodegenerative outcomes and prioritize mediators. In 310 162 European‐ancestry UK Biobank participants, Cox models associate OA with higher risks of Alzheimer's disease (AD; hazard ratio: 1.13, 95% confidence interval: 1.04–1.22), Parkinson's disease (PD; 1.10, 1.00–1.21), and disorders of autonomic nervous system (DANS; 1.36, 1.06–1.74), and RA with higher AD risk (1.37, 1.13–1.67) (all p < 0.05), but not incident PD. Mendelian randomization prioritizes a modest protective genetic effect of RA on PD (odds ratio: 0.93, 0.88–0.99; p = 0.015), without reverse causation. Transcriptome‐wide association and colocalization analyses identify shared RA–PD genes and prioritize Ring Finger Protein 40 ( RNF40 ). In a collagen‐induced arthritis (CIA) and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model, CIA attenuates dopaminergic injury, whereas systemic Rnf40 knockdown alleviates arthritis but exacerbates Parkinsonian pathology. Endogenous RNF40 is induced in arthritic joints but remains stable in midbrain. These cross‐layer data define arthritis–neurodegeneration connections and nominate RNF40 as a context‐dependent joint–brain candidate linking inflammatory arthritis with dopaminergic vulnerability.
- Open Access
- 12 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Hyperglycemia exacerbates osteoarthritis by impairing macrophage efferocytosis through modulation of CD11b lactylation
Osteoarthritis (OA) and diabetes predominantly affect middle-aged and elderly populations, with OA patients frequently presenting with comorbid diabetes. Despite evidence that diabetes aggravates OA progression, the underlying mechanisms are not fully understood. Here, we demonstrate that hyperglycaemia exacerbates OA progression through CD11b lactylation-mediated impairment of macrophage efferocytosis. Mechanistically, hyperglycemia enhances glycolysis in synovial macrophages, leading to lactate accumulation and CD11b lactylation at K575. This post-translational modification alters the conformation of the CD11b protein, impairing recognition of apoptotic cells and compromising synovial macrophage efferocytosis, thereby exacerbating inflammation and accelerating OA progression. Additionally, we identify CBP as a lactyl-transferase whose targeted knockdown in synovial macrophages effectively reduces lactylation levels, restores efferocytosis function, and delays hyperglycemia-associated OA progression. Collectively, our findings represent an important molecular mechanism by which hyperglycemia aggravates OA and suggest that targeting CBP could be utilized as therapeutic strategy for mitigating hyperglycemia-associated OA.
- 12 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessHyperglycemia exacerbates osteoarthritis by impairing macrophage efferocytosis through modulation of CD11b lactylation
Osteoarthritis (OA) and diabetes predominantly affect middle-aged and elderly populations, with OA patients frequently presenting with comorbid diabetes. Despite evidence that diabetes aggravates OA progression, the underlying mechanisms are not fully understood. Here, we demonstrate that hyperglycaemia exacerbates OA progression through CD11b lactylation-mediated impairment of macrophage efferocytosis. Mechanistically, hyperglycemia enhances glycolysis in synovial macrophages, leading to lactate accumulation and CD11b lactylation at K575. This post-translational modification alters the conformation of the CD11b protein, impairing recognition of apoptotic cells and compromising synovial macrophage efferocytosis, thereby exacerbating inflammation and accelerating OA progression. Additionally, we identify CBP as a lactyl-transferase whose targeted knockdown in synovial macrophages effectively reduces lactylation levels, restores efferocytosis function, and delays hyperglycemia-associated OA progression. Collectively, our findings represent an important molecular mechanism by which hyperglycemia aggravates OA and suggest that targeting CBP could be utilized as therapeutic strategy for mitigating hyperglycemia-associated OA.